Business
Currency:GBP
2023/FY
Stock NameRevenueRatio
Development of Ribonucleic acid interference (RNAi)- based medicines25.38M100.00%
Region
Currency:GBP
2023/FY
Stock NameRevenueRatio
U.K.24.81M97.76%
Germany569K2.24%
